Buy-side Firms Reject EMS Brokerage Charges

Some users favor a licence fee over per-trade charging—and have forced vendors to make the switch.

tied together
EMSs connect users to multiple sources of liquidity - but how they charge for the service is contentious

Leading buy-side firms are calling time on the brokerage charging models used by some liquidity aggregators, joining dealers in a growing protest.

In at least two cases, buy-side users of an aggregator have been able to push the vendor into applying an annual license fee instead of per-trade charges.

“There has always been a lot of contention around the way in which EMS and platform fees are charged,” says Ken Monahan, senior analyst on the market structure and technology team at Greenwich

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Waters Wrap: Examining ASX’s CHESS do-over

The Australian exchange was the first exchange to be all-in on DLT—and the project failed. Anthony speaks with ASX’s Tim Whiteley to discuss the lessons learned and why he thinks the second attempt will succeed.

GenAI and HFT: A competitive edge?

Timing is critical in the capital markets. IBM researchers say genAI’s predictive abilities in combination with AI/ML models can translate into profitable HFT opportunities.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here